Abstract
Objective: The transfer of anti-human immunodeficiency virus (HIV) drugs has been studied in the ex vivo human placental model. There is a paucity of information on the placental transfer of these drugs because of ethical considerations and the expense involved in the use of the non-human primate model.
Methods: The standardized ex vivo human placental model was used in these studies and the clearance index in relationship to antipyrine was used to determine the role of transfer of non-nucleosides, nucleosides, and a protease inhibitor. Several of the nucleosides and ritonavir were combined with zidovudine (AZT) to determine the effect of the combinations.
Results: All non-nucleosides, nucleosides, and the protease inhibitor were found to cross the human placenta by simple diffusion, although at variable rates. Ritonavir did not diffuse as rapidly as the nucleosides, but some diffusion was noted at peak concentrations.
Conclusions: Ex vivo perfusion studies agree with those determined in the non-human primate model and with data from existing clinical trials.
Full Text
The Full Text of this article is available as a PDF (511.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bawdon R. E., Kaul S., Sobhi S. The ex vivo transfer of the anti-HIV nucleoside compound d4T in the human placenta. Gynecol Obstet Invest. 1994;38(1):1–4. doi: 10.1159/000292432. [DOI] [PubMed] [Google Scholar]
- Bawdon R. E., Sobhi S., Dax J. The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta. Am J Obstet Gynecol. 1992 Dec;167(6):1570–1574. doi: 10.1016/0002-9378(92)91742-s. [DOI] [PubMed] [Google Scholar]
- Carpenter C. C., Fischl M. A., Hammer S. M., Hirsch M. S., Jacobsen D. M., Katzenstein D. A., Montaner J. S., Richman D. D., Saag M. S., Schooley R. T. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA. 1997 Jun 25;277(24):1962–1969. [PubMed] [Google Scholar]
- Challier J. C. Criteria for evaluating perfusion experiments and presentation of results. Contrib Gynecol Obstet. 1985;13:32–39. [PubMed] [Google Scholar]
- Christmas J. T., Little B. B., Knoll K. A., Bawdon R. E., Gilstrap Iii L. C. Teratogenic and embryocidal effects of Zidovudine (AZT) in sprague-dawley rats. Infect Dis Obstet Gynecol. 1995;2(5):223–227. doi: 10.1155/S1064744995000068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis S. F., Byers R. H., Jr, Lindegren M. L., Caldwell M. B., Karon J. M., Gwinn M. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA. 1995 Sep 27;274(12):952–955. [PubMed] [Google Scholar]
- Deeks S. G., Smith M., Holodniy M., Kahn J. O. HIV-1 protease inhibitors. A review for clinicians. JAMA. 1997 Jan 8;277(2):145–153. [PubMed] [Google Scholar]
- Fortunato S. J., Bawdon R. E., Maberry M. C., Swan K. F. Transfer of ceftizoxime surpasses that of cefoperazone by the isolated human placenta perfused in vitro. Obstet Gynecol. 1990 May;75(5):830–833. [PubMed] [Google Scholar]
- Klug S., Lewandowski C., Merker H. J., Stahlmann R., Wildi L., Neubert D. In vitro and in vivo studies on the prenatal toxicity of five virustatic nucleoside analogues in comparison to aciclovir. Arch Toxicol. 1991;65(4):283–291. doi: 10.1007/BF01968962. [DOI] [PubMed] [Google Scholar]
- Liebes L., Mendoza S., Wilson D., Dancis J. Transfer of zidovudine (AZT) by human placenta. J Infect Dis. 1990 Feb;161(2):203–207. doi: 10.1093/infdis/161.2.203. [DOI] [PubMed] [Google Scholar]
- Odinecs A., Nosbisch C., Keller R. D., Baughman W. L., Unadkat J. D. In vivo maternal-fetal pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in pigtailed macaques (Macaca nemestrina). Antimicrob Agents Chemother. 1996 Jan;40(1):196–202. doi: 10.1128/aac.40.1.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pereira C. M., Nosbisch C., Winter H. R., Baughman W. L., Unadkat J. D. Transplacental pharmacokinetics of dideoxyinosine in pigtailed macaques. Antimicrob Agents Chemother. 1994 Apr;38(4):781–786. doi: 10.1128/aac.38.4.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roberts S., Bawdon R., Sobhi S., Dax J., Gilstrap L., 3rd, Wimberly D. The maternal-fetal transfer of bisheteroypiperazine (U-87201-E) in the ex vivo human placenta. Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):88–91. doi: 10.1016/0002-9378(95)90089-6. [DOI] [PubMed] [Google Scholar]
- Schenker S., Johnson R. F., King T. S., Schenken R. S., Henderson G. I. Azidothymidine (zidovudine) transport by the human placenta. Am J Med Sci. 1990 Jan;299(1):16–20. doi: 10.1097/00000441-199001000-00005. [DOI] [PubMed] [Google Scholar]
- Schneider H., Huch A. Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentation. Contrib Gynecol Obstet. 1985;13:40–47. [PubMed] [Google Scholar]
- Sieh E., Coluzzi M. L., Cusella De Angelis M. G., Mezzogiorno A., Floridia M., Canipari R., Cossu G., Vella S. The effects of AZT and DDI on pre- and postimplantation mammalian embryos: an in vivo and in vitro study. AIDS Res Hum Retroviruses. 1992 May;8(5):639–649. doi: 10.1089/aid.1992.8.639. [DOI] [PubMed] [Google Scholar]
- Toltzis P., Mourton T., Magnuson T. Effect of zidovudine on preimplantation murine embryos. Antimicrob Agents Chemother. 1993 Aug;37(8):1610–1613. doi: 10.1128/aac.37.8.1610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watts D. H., Brown Z. A., Tartaglione T., Burchett S. K., Opheim K., Coombs R., Corey L. Pharmacokinetic disposition of zidovudine during pregnancy. J Infect Dis. 1991 Feb;163(2):226–232. doi: 10.1093/infdis/163.2.226. [DOI] [PubMed] [Google Scholar]
- Wilfert C. M. Beginning to make progress against HIV. N Engl J Med. 1996 Nov 28;335(22):1678–1680. doi: 10.1056/NEJM199611283352210. [DOI] [PubMed] [Google Scholar]